The Association of Dexamethasone and Hydrocortisone with Cerebellar Growth in Premature Infants
Neonatology · 2023
DOI: 10.1159/000531075 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neonatology, 2023. Verfasst von Laura A Warmerdam und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neonatology, Leiden University Medical Center, Leiden, The Netherlands. Hauptthemen laut MEDLINE: Lung Diseases, Bronchopulmonary Dysplasia. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Neonatologie
Abstract (Originalsprache)
Objectives
Corticosteroids are used to prevent or treat lung disease of prematurity. While neurological side effects have been reported, detailed effects on cerebellar growth are unknown. This study aimed to compare cerebellar growth in premature infants who received dexamethasone or hydrocortisone to premature infants who did not receive postnatal corticosteroids. Study Design: Retrospective case-control study in infants born at a gestational age of <29 weeks and admitted to two level 3 neonatal intensive care units. Exclusion criteria were severe congenital anomalies and cerebellar or severe supratentorial lesions. Infants were treated with dexamethasone (unit 1) or hydrocortisone (unit 2) for chronic lung disease. Controls (unit 1) did not receive postnatal corticosteroids. Sequential head circumference (HC) and ultrasound measurements of transcerebellar diameter (TCD), biparietal diameter (BPD), and corpus callosum-fastigium length (CCFL) were performed until 40 weeks’ postmenstrual age (PMA). Growth was assessed using linear mixed models correcting for PMA at measurement, sex, HC z-score at birth, and a propensity score indicating illness severity. Group differences before treatment were assessed using linear regression.
Results
346 infants were included (68 dexamethasone, 37 hydrocortisone, 241 controls). Before starting corticosteroids, TCD, BPD, and HC measurements did not differ between patients and controls at a comparable PMA. After starting treatment, both types of corticosteroid had a negative association with TCD growth. BPD, CCFL, and HC growth were not negatively affected.
Conclusion
Administration of dexamethasone and hydrocortisone are both associated with impaired cerebellar growth in premature infants without evident negative associations with cerebral growth.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neonatology, Leiden University Medical Center, Leiden, The Netherlands.
- Department of Neonatology, Isala Women and Children's Hospital, Zwolle, The Netherlands.
- Department of Neonatology, Wilhelmina Children's Hospital, and Brain Center, University Medical Center Utrecht and Utrecht University, Utrecht, The Netherlands.
Zitieren
APA
Warmerdam, L. A., van Wezel-Meijler, G., de Vries, L. S., Groenendaal, F., & Steggerda, S. J. (2023). The Association of Dexamethasone and Hydrocortisone with Cerebellar Growth in Premature Infants. Neonatology. https://doi.org/10.1159/000531075
Vancouver
Warmerdam LA, van Wezel-Meijler G, de Vries LS, Groenendaal F, Steggerda SJ. The Association of Dexamethasone and Hydrocortisone with Cerebellar Growth in Premature Infants. Neonatology. 2023. doi:10.1159/000531075
BibTeX
@article{Warmerdam2023,
author = {Warmerdam, Laura A and van Wezel-Meijler, Gerda and de Vries, Linda S and Groenendaal, Floris and Steggerda, Sylke J},
title = {The Association of Dexamethasone and Hydrocortisone with Cerebellar Growth in Premature Infants},
journal = {Neonatology},
year = {2023},
doi = {10.1159/000531075}
}
EUVIMED